INS and diabetes mellitus: Additional studies have been limited to therapeutic errors involving single medication categories, such as only insulin (Spiller et al. 2011; Beuhler et al. 2013) or metformin (Stevens et al. 2019), which precluded comparisons among diabetes medication categories.